目的探讨抗抑郁症药物辅助治疗脑出血后伴抑郁症患者的临床疗效。
Objective To investigate and discuss the clinical ettect of anti-depresent in treat patients with post cerebral hemorrhage depression.
尽管如此，该委员会建议FDA仅仅批准该药物用于腰疼的辅助治疗，而不能治疗膝盖关节炎。
However, the panel suggested the FDA only approve Cymbalta as an additional treatment for lower back pain, and not osteoarthritis of the knee.
这一研究也发现，CBT辅助抗抑郁剂的药物治疗可以带给合并焦虑障碍的患者最大的益处。
The study also found that adding cognitive-behavioral therapy(CBT) to antidepressant medications produces the most benefitfor patients who have comorbidities such as anxiety disorders.
应用推荐